Results 41 to 50 of about 1,922,582 (395)

Diabetes mellitus and ischemic heart disease. the role of ion channels [PDF]

, 2018
Diabetes mellitus is one the strongest risk factors for cardiovascular disease and, in particular, for ischemic heart disease (IHD). The pathophysiology of myocardial ischemia in diabetic patients is complex and not fully understood: some diabetic ...
De Marchis, Marialaura, D’Amato, Andrea, Fedele, Francesco, Mancone, Massimo, Netti, Lucrezia, Palmirotta, Raffaele, Pucci, Mariateresa, Severino, Paolo, Volterrani, Maurizio   +8 more
core   +2 more sources

The relation between atherogenic index of plasma and cardiovascular outcomes in prediabetic individuals with unstable angina pectoris

BMC Endocrine Disorders, 2023
Background The atherogenic index of plasma (AIP) is a novel biomarker associated with atherosclerosis, and an important risk factor for atherosclerosis, but its relation with cardiovascular prognosis in prediabetic patients with unstable angina pectoris (
Yang Liu, Xunxun Feng, Jiaqi Yang, Guangyao Zhai, Bin Zhang, Qianyun Guo, Yujie Zhou   +6 more
doaj   +1 more source

Correlation between estimated glucose disposal rate and in-stent restenosis following percutaneous coronary intervention in individuals with non-ST-segment elevation acute coronary syndrome

Frontiers in Endocrinology, 2022
BackgroundInsulin resistance (IR) is closely associated with in-stent restenosis (ISR) following percutaneous coronary intervention (PCI). Nevertheless, the predictive power of the newly developed simple assessment method for IR, estimated glucose ...
Chi Liu, Chi Liu, Qi Zhao, Qi Zhao, Ziwei Zhao, Ziwei Zhao, Xiaoteng Ma, Xiaoteng Ma, Yihua Xia, Yihua Xia, Yan Sun, Yan Sun, Dai Zhang, Dai Zhang, Xiaoli Liu, Xiaoli Liu, Yujie Zhou, Yujie Zhou   +17 more
doaj   +1 more source

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease

European Heart Journal, 2013
Aims The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (FH) is underdiagnosed and undertreated. The second aim was to provide guidance for screening and treatment of FH, in order to prevent coronary heart disease
B. Nordestgaard, M. Chapman, S. Humphries, H. Ginsberg, L. Masana, O. Descamps, O. Wiklund, R. Hegele, F. Raal, J. Defesche, A. Wiegman, R. Santos, G. Watts, K. Parhofer, G. Hovingh, P. Kovanen, C. Boileau, M. Averna, J. Borén, E. Bruckert, A. Catapano, J. Kuivenhoven, P. Pajukanta, K. Ray, A. Stalenhoef, E. Stroes, M. Taskinen, A. Tybjærg‐Hansen   +27 more
semanticscholar   +1 more source

Depression and Coronary Heart Disease [PDF]

ISRN Cardiology, 2012
There are exciting findings in the field of depression and coronary heart disease. Whether diagnosed or simply self-reported, depression continues to mark very high risk for a recurrent acute coronary syndrome or for death in patients with coronary heart disease.
openaire   +3 more sources

The sensibility of the new blood lipid indicator——atherogenic index of plasma (AIP) in menopausal women with coronary artery disease

Lipids in Health and Disease, 2020
Background Dyslipidemia is a key driver of coronary artery disease (CAD) development. This study aimed to determine whether the atherogenic index of plasma (AIP), a novel comprehensive lipid index, is an independent and reliable predictor of CAD risk in ...
Qianyun Guo, Shu Zhou, Xunxun Feng, Jiaqi Yang, Jiaming Qiao, Yingxin Zhao, Dongmei Shi, Yujie Zhou   +7 more
doaj   +1 more source

Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study [PDF]

, 2000
OBJECTIVES: To characterise the clinical features of patients with suspected heart failure but preserved left ventricular systolic function to determine if they have other potential causes for their symptoms rather than being diagnosed with 'diastolic ...
Caruana, L., Davie, A.P., McMurray, J., Petrie, M.C.   +3 more
core   +2 more sources

Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. [PDF]

, 2009
Plasma levels of C-reactive protein (CRP) are independently associated with risk of coronary heart disease, but whether CRP is causally associated with coronary heart disease or merely a marker of underlying atherosclerosis is uncertain.
Anand, S.S., Ashby, D., Bennett, D., Braund, P., Brown, I.J., Chambers, J.C., Clarke, R., Coin, L., Collins, R., Elliott, P., Engert, J.C., Erdmann, J., Farrall, M., Freimer, N.B., Froguel, P., Hall, A.S., Hamsten, A., Hopewell, J.C., Jarvelin, M.R., Kooner, J.S., Lim, N., McCarthy, M.I., Mooser, V., Mt-Isa, S., Peden, J.F., Peltonen, L., Ruokonen, A., Samani, N.J., Schunkert, H., Scott, J., Tzoulaki, I., Vollenweider, P., Waeber, G., Waterworth, D.M., Watkins, H., Zhang, W.   +35 more
core   +1 more source

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Circulation
BACKGROUND: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors ...
Seth S. Martin, A. Aday, Zaid I Almarzooq, Cheryl A M Anderson, Pankaj Arora, Christy L Avery, C. Baker-Smith, Bethany Barone Gibbs, Andrea Z Beaton, Amelia K Boehme, Yvonne Commodore-Mensah, Maria E Currie, Mitchell S. V. Elkind, K. Evenson, Giuliano Generoso, Debra G Heard, Swapnil Hiremath, Michelle C. Johansen, Rizwan Kalani, Dhruv S. Kazi, Darae Ko, Junxiu Liu, Jared W. Magnani, E. Michos, M. Mussolino, S. Navaneethan, N. Parikh, Sarah M Perman, Remy Poudel, M. Rezk-Hanna, G. A. Roth, Nilay S Shah, M. St-Onge, Evan L. Thacker, C. Tsao, Sarah M. Urbut, H. V. Van Spall, Jenifer H. Voeks, Nae-Yuh Wang, Nathan D. Wong, Sally S Wong, Kristine Yaffe, Latha P. Palaniappan   +42 more
semanticscholar   +1 more source

Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Stage 4 Cardiovascular–Kidney–Metabolic Syndrome: A Propensity Score–Matched Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background This study investigated the effects of sodium–glucose cotransporter 2 inhibitors (SGLT2is) on patients with stage 4 cardiovascular–kidney–metabolic syndrome over 1 year.
Tao Liu, Zeyuan Fan, Yuntao Li, Bing Xiao, Chang He   +4 more
doaj   +1 more source